Skylight Health Group (TSXV: SHG) is the latest firm to set its sights on the Nasdaq. The company this morning announced that it has submitted an application to list its shares on the US big board exchange.
The company this morning outlined a number or reasons as for why it is seeking a US listing, which primarily come down to increased exposure. The company is looking to expand its institutional and retail investor base, while improving the visibility of its equity – which the big board exchange is known for thanks to the rising prominence of discount brokerages.
Through the listing the company also is looking to drive growth through M&A, while also improving the liquidity of its common shares. Overall, the company appears to see it as the easiest path to improving shareholder value.
The listing remains subject to approval. The company has indicated that it intends to remain listed on the Venture Exchange within Canada, even if the big board listing is approved.
Skylight Health Group last traded at $1.38 on the TSX Venture.
Information for this briefing was found via Sedar and Skylight Health Group. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.